Non-PVC IV Bags Market Size Worth $3.19 Billion By 2028 | CAGR: 9.9%

Non-PVC IV Bags Market Size Worth $3.19 Billion By 2028 | CAGR: 9.9%

The global non-PVC IV bags market size is expected to reach USD 3.19 billion by 2028 according to a new study by Polaris Market Research. The report “Non-PVC IV Bags Market Share, Size, Trends, Industry Analysis Report, By Product (Single Chamber, Multi-Chamber); By Material; By Content (Frozen Mixture, Liquid Mixture); By Region; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.


Major factors contributing to the upward growth of the global market include the adoption of advanced materials for the production of containers along with the increase in the use of chemotherapy in oncology. The other driving factors for the growth of the market are improved healthcare infrastructure in developing economies and stringent regulations against the production of PVC containers.


The increase in cases of cancer has increased the use of chemotherapy drugs. In the U.S. alone there were around 1.8 million cancer cases diagnosed, in 2020. It is estimated that the use of chemotherapy will be increased by 53% between 2018 and 2040. The emergence of new targeted drugs in cancer therapeutics has increased the chemotherapy in cancer treatment when compared to other forms of cancer treatment.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:


Non-PVC bags are of two types that include single chamber and multiple chamber bags. Single chambers are most widely used as they are suitable for drips and storage of sterile water. The containers are used to pack both the liquid mixture and the frozen mixture. containers are primarily used in liquid mixtures since these containers are adopted more in blood banks and drips. Frozen mixtures such as methylprednisolone and ceftriaxone are also packaged in non-PVC containers.


Companies are increasingly introducing new products in the industry. In March 2021, Fagron Sterile Services U.S. launched a new platform of intravenous (IV) containers for the packaging of COVID-19 medications such as HYDROmorphone, fentaNYL, and Midazolam. In December 2020, Fresenius Kabi announced the introduction of acetaminophen injection in free flex containers for the U.S. market.


COVID-19 is expected to fuel the growth of the global industry for non-PVC containers during the forecast period. The severely infected need hospitalization and they will require ventilator and oxygen support. The increased hospitalization will increase the usage of bags in the treatment of COVID-related complications.


Polaris Market Research has segmented the non-PVC IV bags market report on the basis of product, material, content, and region:

Non-PVC IV Bags, Product Outlook (Revenue - USD Million, 2016 – 2028)

  • Single Chamber
  • Multi-Chamber

Non-PVC IV Bags, Material Outlook (Revenue - USD Million, 2016 – 2028)

  • Ethylene Vinyl Acetate
  • Polypropylene
  • Co-polyester Ether
  • Others

Non-PVC IV Bags, Content Outlook (Revenue - USD Million, 2016 – 2028)

  • Frozen Mixture
  • Liquid Mixture

Non-PVC IV Bags, Regional Outlook (Revenue - USD Million, 2016 – 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Austria
    • Netherlands
    • Russia
  • Asia Pacific
    • China
    • Japan
    • India
    • Indonesia
    • Malaysia
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East and Africa
    • Israel
    • Saudi Arabia
    • South Africa
    • UAE